Page last updated: 2024-09-05

phosphatidylcholines and butaprost

phosphatidylcholines has been researched along with butaprost in 1 studies

Compound Research Comparison

Studies (phosphatidylcholines)	Trials (phosphatidylcholines)	Recent Studies (post-2010) (phosphatidylcholines)	Studies (butaprost)	Trials (butaprost)	Recent Studies (post-2010) (butaprost)
32,204	443	5,593	161	0	46

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berliner, JA; Cruz, D; Dun, M; Gharavi, N; Koroniak, L; Li, R; Montoya, D; Mouillesseaux, KP	1

Other Studies

1 other study(ies) available for phosphatidylcholines and butaprost

Article	Year
Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. Circulation research, 2006, Mar-17, Volume: 98, Issue:5 Topics: Alprostadil; Atherosclerosis; Cells, Cultured; Dinoprostone; Foam Cells; Humans; Interleukin-10; Isoprostanes; Macrophages; Monocytes; Oxidation-Reduction; Phosphatidylcholines; Phospholipid Ethers; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; RNA, Messenger; Tumor Necrosis Factor-alpha; Xanthones	2006

Article

Year

Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC.

Circulation research, 2006, Mar-17, Volume: 98, Issue:5

Topics: Alprostadil; Atherosclerosis; Cells, Cultured; Dinoprostone; Foam Cells; Humans; Interleukin-10; Isoprostanes; Macrophages; Monocytes; Oxidation-Reduction; Phosphatidylcholines; Phospholipid Ethers; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; RNA, Messenger; Tumor Necrosis Factor-alpha; Xanthones

2006